1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid has been researched along with Animal Mammary Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hisada, H; Maeda, M; Mukai, T; Okada, M; Saji, H; Sano, K; Shimokawa, K | 1 |
1 other study(ies) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Animal Mammary Carcinoma
Article | Year |
---|---|
In vivo evaluation of a radiogallium-labeled bifunctional radiopharmaceutical, Ga-DOTA-MN2, for hypoxic tumor imaging.
Topics: Animals; Cell Line, Tumor; Contrast Media; Female; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Hypoxia; Mammary Neoplasms, Animal; Metronidazole; Mice; Mice, Inbred C3H; Positron-Emission Tomography; Tissue Distribution | 2013 |